Sialidase inhibitors related to zanamivir: Synthesis and biological evaluation of 4H-pyran 6-ether and ketone

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 4, 1999, Pages 601-604

  Smith, Paul W ^a   Robinson, J Ed ^a   Evans, Derek N ^a   Sollis, Steven L ^a   Howes, Peter D ^a   Trivedi, Naimisha ^a   Bethell, Richard C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 5 ACETAMIDO 4 AMINO 4H PYRAN 6 2 (1 ETHYL)PROPYL 3 CARBOXYLIC ACID; 6 (1 OXO 2 ETHYL)BUTYL 2 CARBOXYLIC ACID; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

ARTICLE; DRUG POTENCY; DRUG SPECIFICITY; DRUG SYNTHESIS; ENZYME INHIBITION; INFLUENZA VIRUS; INFLUENZA VIRUS A; INHIBITION KINETICS;

ENZYME INHIBITORS; GUANIDINES; KETONES; NEURAMINIDASE; PYRANS; SIALIC ACIDS; ZANAMIVIR;

INFLUENZA VIRUS;

EID: 0033593918     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00031-1     Document Type: Article

References (17)

1. 1. Bethell, R.C.; Smith P.W. Expert Opin. Invest. Drugs 1997, 6, 1501-1509.
2. 2. Kim, C.U.; Lew, W.; Williams, M.A.; Zhang, L.; Liu, H.; Swaminathan, S.; Bischofberger, N.; Chen, M.S.; Tai, C.Y.; Mendel, D.B.; Laver, W.G.; Stevens, R.C. J. Am. Chem. Soc. 1997, 119, 681-690.
3. 3. Kim, C.U.; Lew, W.; Williams, M.A.; Wu, H.; Zhang, L.; Chen, X.; Escarpe, P.A.; Mendel, D.B.; Laver, W.G.; Stevens, R.C. J. Med. Chem 1998, 41, 2451-2460.
4. 4. Smith, P.W.; Sollis, S.L.; Howes, P.D.; Cherry, P.C.; Starkey, I.D.; Cobley, K.N.; Weston, H; Scicinski, J; Merritt, A; Whittington, A; Wyatt, P; Taylor, N; Green, D; Bethell, R.C; Madar, S; Fenton, R.J.; Morley, P.J.; Pateman, T; Beresford, A. J. Med. Chem. 1998, 41, 787-797.
5. 5. Taylor, N.R.; Cleasby, A; Singh, O; Skarzynski, T; Wonacott, A.J.; Smith, P.W.; Sollis, S.L.; Howes, P.D.; Cherry, P.C.; Bethell, R; Colman, P; Varghese, J. J. Med. Chem. 1998, 41, 798-807.
6. 6. Babu, Y.S.; Chand, P; Montgomery, J.A. PCT Int. Appl., WO 9747194
7. 7. Chand, P; Babu, Y.S.; Bantia, S; Chu, N; Cole, L.B; Kotian, P.L.; Laver, W.G; Montgomery, J.A.; Pathak, V.P.; Petty, S.L.; Shrout, D.P.; Walsh, D.A.; Walsh, G.M. J. Med. Chem. 1997, 40, 4030-4052.
8. 8. Horton, D. Org Synth Coll Vol 1973, 5, 1-5
9. 9. von Itzstein, M; Jin, B; Wu, W-Y; Chandler, M. Carbohydr. Res. 1993, 244, 181-5.
10. 10. Smith, P.W.; Starkey, I.D.; Howes, P.D.; Sollis, S.L.; Keeling, S.P.; Cherry, P.C.; von Itzstein, M.; Wu, W.Y.; Jin, B. Eur. J. Med. Chem. 1996, 31, 143-50.
11. 11. Satisfactory spectroscopic and analytical data was obtained for all new compounds
12. 12. Seyferth, D.; Goldman, W.E,; Pornet, J. J. Organometallic chemistry 1981, 208, 189-193
13. 13. Nishigaichi, Y,; Fujimoto, M, Takuwa, A. J. Chem.Soc Perkin I, 1992, 2581-2582
14. 14. Ley, S.V.; Norman, J; Griffith, W.P.; Marsden, S.P. Synthesis 1994, 639-66.
15. 50 value quoted is the concentration of inhibitor required to reduce the enzymic activity in this preparation by 50%.
16. 5,6 = 10Hz
17. 17. Blattner, R.; Ferrier, R.J.; Tyler, P.C. J.Chem.Soc.Perkin.Trans.I, 1980, 1535.